Actively Recruiting
CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients
Led by Istanbul University - Cerrahpasa · Updated on 2026-05-12
100
Participants Needed
1
Research Sites
10 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index, Clinical Frailty Scale (CFS), and SOFA-2 score in predicting mortality among geriatric intensive care unit (ICU) patients. The primary outcome is ICU mortality. Secondary outcomes include 28-day mortality, ICU length of stay, duration of mechanical ventilation, need for renal replacement therapy, and vasopressor requirement. The study also investigates whether the combined use of these parameters improves predictive performance compared to conventional scoring systems such as APACHE II.
CONDITIONS
Official Title
CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years or older
- Admission to the intensive care unit
- Availability of required clinical and laboratory data within the first 24 hours of ICU admission
You will not qualify if you...
- Death within the first 24 hours after ICU admission
- Missing key clinical or laboratory data
- Terminal malignancy receiving palliative care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Başakşehir Çam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
T
TUGBA Yesilyurt Dogu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here